JP Morgan Chase
AXSM icon

JP Morgan Chase’s Axsome Therapeutics AXSM Stock Holding History

JP Morgan Chase’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17,500
Closed -$3.2M – 7524
2025
Q4 		$3.2M Buy
+17,500
New +$2.44M ﹤0.01% 3709
2025
Q1 		– Sell
-67,700
Closed -$5.73M – 7323
2024
Q4 		$5.73M Buy
+67,700
New +$6.23M ﹤0.01% 3221
2022
Q4 		– Sell
-2,200
Closed -$98K – 6536
2022
Q3 		$98K Buy
+2,200
New +$110K ﹤0.01% 5295
2020
Q2 		– Sell
-50,000
Closed -$2.94M – 5362
2020
Q1 		$2.94M Buy
+50,000
New +$4.07M ﹤0.01% 2677
2019
Q3 		– Sell
-375,000
Closed -$9.52M – 5711
2019
Q2 		$9.52M Sell
375,000
-125,000
-25% -$2.51M ﹤0.01% 2139
2019
Q1 		$7.12M Buy
+500,000
New +$4.64M ﹤0.01% 2320

Other funds holding AXSM

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return